➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

Watson Labs Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for WATSON LABS, and what generic and branded alternatives to WATSON LABS drugs are available?

WATSON LABS has one thousand and thirty-seven approved drugs.

There are eighteen tentative approvals on WATSON LABS drugs.

Summary for Watson Labs

US Patents:	0
Tradenames:	401
Ingredients:	378
NDAs:	1037

Drugs and US Patents for Watson Labs

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	TETRACYCLINE HYDROCHLORIDE	tetracycline hydrochloride	CAPSULE;ORAL	062343-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Watson Labs Teva	FENOPROFEN CALCIUM	fenoprofen calcium	TABLET;ORAL	072407-001	Aug 17, 1988		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Watson Labs	ENALAPRIL MALEATE	enalapril maleate	TABLET;ORAL	075501-002	Aug 22, 2000		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Watson Labs	SULFINPYRAZONE	sulfinpyrazone	TABLET;ORAL	087667-001	May 26, 1982		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Watson Labs	CORTISONE ACETATE	cortisone acetate	INJECTABLE;INJECTION	083147-003	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Watson Labs	CLONAZEPAM	clonazepam	TABLET;ORAL	074964-003	Dec 30, 1997		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Watson Labs Teva	DIMENHYDRINATE	dimenhydrinate	INJECTABLE;INJECTION	080615-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Colorcon

McKesson

Dow

Moodys

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.